Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/28/2026

1. SPY
2. CDNS
3. NVDA
4. AAPL
5. USO
6. META
7. FFIV
8. TFII
9. XFLT
10. AMZN

Go back to Oncopeptides Completes Patient Enrollment in Phase 2 PORT Study
Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.83 +0.02 (2.47%)
Previous Close $0.81    52 Week High $0.00 
Open $0.82    52 Week Low $0.00 
Day High $0.84    P/E N/A 
Day Low $0.78    EPS $0.00 
Volume 152,434       

Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.83 +0.02 (2.47%)
Previous Close $0.81    52 Week High $0.00 
Open $0.82    52 Week Low $0.00 
Day High $0.84    P/E N/A 
Day Low $0.78    EPS $0.00 
Volume 152,434       

Oncology Med, Inc. (NASDAQ: ONCO) Delayed: 0.83 +0.02 (2.47%)
Previous Close $0.81    52 Week High $0.00 
Open $0.82    52 Week Low $0.00 
Day High $0.84    P/E N/A 
Day Low $0.78    EPS $0.00 
Volume 152,434